Etablishing precompetitive collaborations to stimulate genomics-driven drug development
Subtitle: workshop summary
By: Steve Olson and Adam C. Berger, rapporteurs ;  Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Contributors: Olson, Steve, 1956-; Berger, Adam C.
Publisher: National Academies Press
Published: 2011
Place of publication: Washington, D.C
Language: eng
Number of pages: 74
ISBN-13: 9780309161824
Subjects: Genomics; Moral and ethical aspects; Government policy; Human genome; Gene therapy; Public-private sector cooperation
Description: "Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that share resources while distributing risk. However, intellectual property protections and other barriers can inhibit collaborative efforts. The Institute of Medicine held a workshop on July 22, 2010, to explore these issues and develop solutions."--Publisher's description.
Notes: Includes bibliographical references.

Also available online.
Table of contents: title: Introduction; title: A lesson about precompetitive collaboration; title: Requisites for successful precompetitive collaboration; title: Frameworks for collaboration; title: The use of biospecimens in precompetitive collaborations; title: Ethical challenges in the use of biospecimens; title: Toward developing a cultural, legal, and behavioral framework for precompetitive collaboration.